US Patent 11974971 Compositions and methods for treating metabolic disorders
Patent 11974971 was granted and assigned to Anji Pharmaceuticals on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+47 properties)
Article (+431 characters)
US Patent 11974971 Compositions and methods for treating metabolic disorders
Article
Patent abstract
Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alain D. Baron0
Mark S. Fineman0
Nigel R. A. Beeley0
Date of Patent
May 7, 2024
0Patent Application Number
162730790
Date Filed
February 11, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11974971 Compositions and methods for treating metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
